Close
Back to PCYC Stock Lookup

Pharmacyclics (PCYC) – Hot FDA News

Mar 16, 2015 03:01 PM Pharmacyclics (PCYC) Reports IMBRUVICA Combo Phase 3 Met Primary Endpoint in CLL, SLL; Study Will be Unblinded
Feb 12, 2014 12:50 PM FDA Approves Imbruvica to Treat Chronic Lymphocytic Leukemia (PCYC)
Jan 7, 2014 09:32 AM
Nov 13, 2013 12:24 PM
Mar 2, 2011 08:32 AM

Back to PCYC Stock Lookup